Antihistamines, Pepcid, and Menopause Brain Fog
A look at the Internet's Latest Fix
If you’ve spent any time on Instagram, Threads, TikTok, or Reddit in the past few weeks, you may have seen people recommending antihistamines (H1 blockers) and/or acid blockers (H2 blockers), think cetirizine (Zyrtec) and famotidine (Pepcid), as a treatment for menopause brain fog.
There are no studies showing that antihistamines or acid-blockers improve cognitive symptoms in menopause; there isn’t even observational data. This is a hypothesis.
It is true that women’s health is understudied, and we have precious few studies looking at brain fog. This means that yes, there are likely many undiscovered therapies out there, but when some random new menopause home brew pops up, it’s important be wary, as algorithms and bad actors can take advantage of gaps in medicine.
The best we can do in this situation is to look at the biology and ask two questions
Is this a reasonable hypothesis?
Is there potential for harm?
Fair warning, this is a long post. Much of the online content glosses over the potential mechanisms, and there are so many wild claims, that I felt it was necessary to walk through everything as methodically as possible. It is the only way that I know to make sense out of that kind of chaos.
A Histamine Primer
Histamine is a chemical messenger stored in tiny granules within mast cells and basophils, ready to be released when needed. It is also produced in the stomach and in the brain.
There are four kinds of histamine receptors, each with different actions. Here we are discussing medications that target two of these histamine receptors:
H1 receptors, which are involved in allergic and inflammatory responses, and mediate many classic allergic symptoms, such as sneezing, itching, hives, watery eyes, swelling, and wheezing. This is why we use H1 blockers to treat allergies. We also have H1 receptors in the brain, where they promote wakefulness. This is why older H1 blockers that cross the blood-brain barrier cause drowsiness.
H2 receptors are found in the stomach lining, and they stimulate parietal cells to produce stomach acid. This is why H2 blockers can treat heartburn.
Is there the Hormone-Histamine Relationship?
Estrogen is generally pro-allergenic, although there is nuance depending on dose. Estradiol activates mast cells, releasing histamine and other allergic mediators. It also enhances the effects of IgE (an antibody the immune system produces when it determines that something, such as pollen or certain foods, is a threat). This means that during the reproductive years, when estrogen levels are high, women tend to experience their greatest histamine release from mast cells. After menopause, when estrogen drops, there is less stimulation.
What about progesterone? It is more complicated: it appears to suppress histamine release from mast cells, but it increases IgE production. This means there is a duality: progesterone can both suppress and amplify the allergic response.
Considering the hormonal chaos of the menopause transition, some cycles with higher than normal estradiol, some cycles with lower estradiol, and some cycles with little or no progesterone, there could theoretically be unpredictable allergy responses. And to add another layer of complexity, there can be inflammatory changes associated with menopause that could also have downstream effects on histamine and allergic responses.
This may be why some women notice their allergies change around menopause, improving for some and worsening for others. There is likely a lot of individual variability given the permutations and combinations of hormone levels, our genetics, and the allergens to which we are exposed.
There is some data linking menopause hormone therapy to an increased risk of asthma. Over the years, I have had a couple of patients who could not take any menopause hormone therapy because each time they started estrogen, their asthma deteriorated significantly. These kinds of experiences always reinforce for me that people can be outliers, so it’s important to keep an open mind about the possibilities.
What about the Combination of H1 and H2 Blockers for Brain Fog?
The idea of taking both an H1 and an H2 blocker together for brain fog appears (to me anyway) to be borrowed partly from the treatment of mast cell activation syndrome (MCAS), where this is a recognized therapy. However, MCAS is a very specific
